MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Movement-related modulation of beta/high frequency oscillations and low-beta pallido-cortical coherence in Parkinson’s disease.

    J. Aman, L. Johnson, J. Wang, D. Escobar Sanabria, M. Hill, S. Alberico, K. O'Neill, R. Patriat, N. Harel, S. Cooper, D. Darrow, R. Mcgovern Iii, M. Park, J. Vitek (Minneapolis, USA)

    Objective: To characterize changes in synchronized oscillatory activity and coherence between the globus pallidus (GPi) and primary motor cortex (M1) of Parkinson’s disease (PD) patients…
  • 2023 International Congress

    Clinical characterization of patients with functional movement disorders

    Y. Guzman, A. Soto, T. Saldivar (Mexico City, Mexico)

    Objective: To clinically characterize functional movement disorders in a Cuban cohort. Background: Functional movement disorders are those that cannot be explained by an organic disease…
  • 2023 International Congress

    Gait cycle-related neural activity during cued and uncued gait in Parkinson’s disease patients

    F. Gennaro, I. Talu, K. Cross (Padova, Italy)

    Objective: To Investigate the effects of cueing on gait kinematics and neural activity in Parkinson’s disease (PD) using electroencephalography (EEG). Background: Sensory cueing strategies can…
  • 2023 International Congress

    Movement disorders in children with neurometabolic and neurodegenerative disorders: A single-center prospective study

    A. Saini, S. Khanna, N. Sankhyan (Chandigarh, India)

    Objective: To analyze the prevalence, patterns and severity of movement disorders in children with genetically proven neurometabolic and neurodegenerative diseases. Background: Movement disorders are often…
  • 2023 International Congress

    Improvement in spasticity-associated dressing- and hygiene-related disability in adults following treatment with incobotulinumtoxinA: a pooled analysis

    F. Molteni, J. Wissel, K. Fheodoroff, M. Munin, A. Patel, M. Althaus, G. Comes, A. Dekundy, I. Pulte, A. Scheschonka, M. Vacchelli, A. Santamato (Costa Masnaga, Italy)

    Objective: To evaluate impact of incobotulinumtoxinA (incoA) on dressing- and hygiene-related disability (DRE and HYG) in adults with upper-limb spasticity (ULS) based on pooled data…
  • 2023 International Congress

    Generalized dystonia and spasticity: The fault in the mitochondria

    A. Saini, S. Khanna (Chandigarh, India)

    Objective: To analyze the pattern of movement disorder in a child with mitochondrial respiratory chain disorder Background: Secondary movement disorders are often a clue to…
  • 2023 International Congress

    Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.

    K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, F. Tanaka (Yokohama, Japan)

    Objective: To clarify the the clinical background of Parkinson's disease patients with DBS who received multiple stimulus targets. Background: Deep brain stimulation (DBS) is an…
  • 2023 International Congress

    Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.

    D P. Romero Teran, A J. Hernández Medrano, D R. Aguila Godinez, A A. Herrera Ruiz, E C. Santiago Cruz, M. Medrano Delgado, M A. Ruiz Mafud, A Y. Regalado Mustafá, M F. Medina Perez, G I. Cerda Hernández, M. Rodriguez Violante, A. Cervantes Arriaga, G. Hernandez Armesto, A. Abundes Corona, A. Dominguez Garcia, K. Talavera Lagunas (CDMX, Mexico)

    Objective: To provide data about the movement disorders (MD) outpatient consultation (OC) service from the INNN, Mexico City during 2022. Background: The INNN, inaugurated in…
  • 2023 International Congress

    The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.

    V. Mathur, A. Shetty, P. Wadia (Jaipur, India)

    Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • « Previous Page
  • 1
  • …
  • 635
  • 636
  • 637
  • 638
  • 639
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley